Retinopathy of Prematurity

Critical Care Nursing Clinics of North America

Volumn 21, Issue 2, 2009, Pages 213-233

  Askin, Debbie Fraser ^a,b,c   Diehl Jones, William ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

^b UNIVERSITY OF MANITOBA   (Canada)

^c ST BONIFACE GENERAL HOSPITAL   (Canada)

Author keywords

Eye disease; Newborn; Premature; Retinopathy of prematurity; Very low birth weight neonate

Indexed keywords

SOMATOMEDIN C; VASCULOTROPIN A;

CLASSIFICATION; CRYOTHERAPY; HOSPITALIZATION; HUMAN; LASER COAGULATION; LOW BIRTH WEIGHT; METHODOLOGY; NEWBORN; NEWBORN INTENSIVE CARE; NEWBORN NURSING; NEWBORN SCREENING; NURSING; NUTRITIONAL SUPPORT; OXYGEN THERAPY; PHYSIOLOGY; PRACTICE GUIDELINE; PROGNOSIS; RETINA DETACHMENT; RETROLENTAL FIBROPLASIA; REVIEW; RISK FACTOR;

CRYOTHERAPY; HUMANS; INFANT, LOW BIRTH WEIGHT; INFANT, NEWBORN; INSULIN-LIKE GROWTH FACTOR I; INTENSIVE CARE, NEONATAL; LASER COAGULATION; NEONATAL NURSING; NEONATAL SCREENING; NUTRITIONAL SUPPORT; OXYGEN INHALATION THERAPY; PRACTICE GUIDELINES AS TOPIC; PROGNOSIS; RETINAL DETACHMENT; RETINOPATHY OF PREMATURITY; RISK FACTORS; SEVERITY OF ILLNESS INDEX; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 65549094046     PISSN: 08995885     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ccell.2009.01.002     Document Type: Review

References (152)

1. Lad E.M., Nguyen T.C., Morton J.M., et al. Retinopathy of prematurity in the United States. Br J Ophthalmol 92 3 (2008) 320-325
2. Terry T.L. Extreme prematurity and fibroblastic overgrowth of persistent vascular sheath behind each crystalline lens. Am J Ophthalmol 25 2 (1942) 203-204
3. Patz A., Hoeck L.E., and DeLaCruz E. Studies on the effect of high oxygen administration in retrolental fibroplasia. I. Nursery observations. Am J Ophthalmol 35 (1952) 1248-1253
4. Kinsey V.E. Cooperative study of retrolental fibroplasia and the use of oxygen. Arch Ophthalmol 56 (1956) 481-543
5. Cross K.W. Cost of preventing retrolental fibroplasia?. Lancet 2 835 (1973) 954-956
6. Phelps D.L. Retinopathy of prematurity: an estimate of visual loss in the United States. Pediatrics 67 6 (1981) 924-925
7. Palmer E.A., Flynn J.T., Hardy R.J., et al. Incidence and early course of retinopathy of prematurity. The Cryotherapy for Retinopathy of Prematurity Cooperative Group. Ophthalmology 98 11 (1991) 1628-1640
8. Steinkuller P.G., Du L., Gilbert C., et al. Childhood blindness. J AAPOS 3 1 (1999) 26-32
9. Gilbert C., Rahi J., Eckstein M., et al. Retinopathy of prematurity in middle-income countries. Lancet 350 9070 (1997) 12-14
10. Saugstad O.D. Oxygen and retinopathy of prematurity. J Perinatol 26 (2006) S46-S50
11. Gilbert C. Retinopathy of prematurity: a global perspective of the epidemics, population of babies at risk and implications for control. Early Hum Dev 84 2 (2008) 77-82
12. Gilbert C., Fielder A., Gordillo L., et al., International NO-ROP Group. Characteristics of infants with severe retinopathy of prematurity in countries with low, moderate, and high levels of development: implications for screening programs. Pediatrics 115 5 (2005) e518-e525
13. Fleck B.W., and McIntosh N. Pathogenesis of retinopathy of prematurity and possible preventative strategies. Early Hum Dev 84 (2008) 83-88
14. Good W.V., Hardy R.J., Dobson V., et al., Early Treatment for Retinopathy of Prematurity Cooperative Group. The incidence and course of retinopathy of prematurity: findings from the early treatment for retinopathy of prematurity study. Pediatrics 116 1 (2005) 15-23
15. Hardy R.J., Palmer E.A., Dobson V., et al. Risk analysis of prethreshold ROP. Arch Ophthalmol 121 (2003) 1699-1701
16. O'Connor M.T., Vohr B.R., Tucker R., et al. Is retinopathy of prematurity increasing among infants less than 1250 g birthweight?. J Perinatol 23 8 (2003) 673-678
17. Chow L.C., Wright K.W., Sola A., and CSMC Oxygen Administration Study Group. Can changes in clinical practice decrease the incidence of severe retinopathy of prematurity in very low birth weight infants?. Pediatrics 111 2 (2003) 339-345
18. Alme A.M., Mulhern M.L., Hejkal T.W., et al. Outcome of retinopathy of prematurity patients following adoption of revised indications for treatment. BMC Ophthalmol 8 1 (2008) 23
19. International Committee for the Classification of Retinopathy of Prematurity. The International classification of retinopathy of prematurity revisited. Arch Ophthalmol 123 7 (2005) 991-999
20. American Academy of Pediatrics Section on Ophthalmology, American Academy of Ophthalmology, and American Association for Pediatric Ophthalmology and Strabismus. Screening examination of premature infants for retinopathy of prematurity. Pediatrics 117 2 (2006) 572-576
21. Schaffer D.B., Palmer E.A., Plotsky D.F., et al. Prognostic factors in the natural course of retinopathy of prematurity. The Cryotherapy for Retinopathy of Prematurity Cooperative Group. Ophthalmology 100 2 (1993) 230-237
22. Clark D., and Mandal K. Treatment of retinopathy of prematurity. Early Hum Dev 84 (2008) 95-99
23. William V.G., and Early Treatment for Retinopathy of Prematurity Cooperative Group. Final results of the Early Treatment for Retinopathy of Prematurity (ETROP) randomized trial. Trans Am Ophthalmol Soc 102 (2004) 233-248
24. Smith L.E. Pathogenesis of retinopathy of prematurity. Semin Neonatol 8 (2003) 469-473
25. Chen J., and Smith L.E. Retinopathy of prematurity. Angiogenesis 10 2 (2007) 133-140
26. Chan-Ling T., Gock B., and Stone J. Supplemental oxygen therapy: basis for noninvasive treatment of retinopathy of prematurity. Invest Ophthalmol Vis Sci 36 (1995) 1215-1230
27. Smith L.E. Pathogenesis of retinopathy of prematurity. Acta Paediatr Suppl 91 437 (2002) 26-28
28. Smith LE, Shen W, Perruzzi C, et al. Regulation of vascular endothelial growth factor-dependent retinal neovascularization by insulin-like growth factor-1 receptor. Nat Med 1999;5:1390-95.
29. Hellstrom A., Pernuzzi C., Ju M., et al. Low IGF-1 suppresses VEGF-a survival signaling in retinal endothelial cells: direct correlation with clinical retinopathy of prematurity. Proc Natl Acad Sci U S A 98 (2001) 5804-5808
30. Stout A.U., and Stout J.T. Retinopathy of prematurity. Pediatr Clin North Am 50 1 (2003) 77-87
31. Gu X.G., El-Remessy A.B., Brooks S.E., et al. Hyperoxia induces retinal vascular endothelial cell apoptosis through formation of peroxynitrite. Am J Physiol, Cell Physiol 285 (2003) C546-C554
32. Kim T.I., Sohn J., Pi S.Y., et al. Postnatal risk factors of retinopathy of prematurity. Paediatr Perinat Epidemiol 18 2 (2004) 130-134
33. Quinn G.E. The 'ideal' management of retinopathy of prematurity. Eye 19 10 (2005) 1044-1049
34. Tasman W., Patz A., McNamara J.A., et al. Retinopathy of prematurity: the life of a lifetime disease. Am J Ophthalmol 141 1 (2006) 167-174
35. Flynn J.T. Acute proliferative retrolental fibroplasia: multivariate risk analysis. Trans Am Ophthalmol Soc 81 (1983) 549-591
36. Lucey J.F., and Dangman B. A reexamination of the role of oxygen in retrolental fibroplasia. Pediatrics 73 1 (1984) 82-96
37. Buksh M.J., Dai S., and Kuschel C.A. AP-ROP in an infant with minimal oxygen exposure. Paediatr Child Health 44 4 (2008) 228-230
38. Campbell K. Intensive oxygen therapy as a possible cause of retrolental fibroplasias: a clinical approach. Med J Aust 2 (1951) 48-50
39. Ashton N., and Cook C. Direct observation of the effect of oxygen on developing vessels: preliminary report. Br J Ophthalmol 38 (1954) 433-440
40. 2 levels and retrolental fibroplasia: a report of the cooperative study. Pediatrics 60 5 (1977) 655-668
41. Bancalari E., Flynn J., Goldberg R.N., et al. Influence of transcutaneous oxygen monitoring on the incidence of retinopathy of prematurity. Pediatrics 79 5 (1987) 663-669
42. Cunningham S., Fleck B.W., Elton R.A., et al. Transcutaneous oxygen levels in retinopathy of prematurity. Lancet 346 (1995) 1464-1465
43. York J.R., Landers S., Kirby R.S., et al. Arterial oxygen fluctuation and retinopathy of prematurity in very-low-birth-weight infants. J Perinatol 24 2 (2004) 82-87
44. Flynn J.T., Bancalari E., Snyder E.S., et al. A cohort study of transcutaneous oxygen tension and the incidence and severity of retinopathy of prematurity. N Engl J Med 326 16 (1992) 1050-1054
45. Hesse L., Eberl W., and Schlaud M. Blood transfusion. Iron load and retinopathy of prematurity. Eur J Pediatr 156 (1997) 465-470
46. Batton D.G., Roberts C., and Trese M. Severe retinopathy of prematurity and steroid exposure. Pediatrics 90 (1992) 534-536
47. Gallo J.E., Jacobsen L., and Broberger U. Perinatal factors associated with retinopathy of prematurity. Acta Paediatr Scand 82 (1993) 829-834
48. McColm J.R., and Fleck B.W. Retinopathy of prematurity: causation. Semin Neonatol 6 (2001) 453-460
49. STOP-ROP Multicenter Study Group. Supplemental Therapeutic Oxygen for Prethreshold Retinopathy Of Prematurity (STOP-ROP), a randomized, controlled trial. I: primary outcomes. Pediatrics 105 2 (2000) 295-310
50. Lloyd J., Askie L., Smith J., et al. Supplemental oxygen for the treatment of prethreshold retinopathy of prematurity. Cochrane Database Syst Rev 2 (2003) CD003482
51. Hellström A., Engström E., Hård A.L., et al. Postnatal serum insulin-like growth factor I deficiency is associated with retinopathy of prematurity and other complications of premature birth. Pediatrics 112 5 (2003) 1016-1020
52. Brown D.R., Milley J.R., and Ripepi U.J. Retinopathy of prematurity. Risk factors in a five-year cohort of critically ill premature neonates. Am J Dis Child 141 (1987) 154-160
53. Mariani G., Cifuentes J., and Carlo W.A. Randomised trial of permissive hypercapnia in preterm infants. Pediatrics 104 (1999) 1082-1088
54. Gellen B., McIntosh N., and McColm J.R. Is the partial pressure of carbon dioxide in the blood related to the development of retinopathy of prematurity?. Br J Ophthalmol 85 (2001) 1044-1045
55. Berkowitz B.A. Adult and newborn rat inner retinal oxygenation during carbogen and 100% oxygen breathing. Invest Ophthalmol Vis Sci 37 (1996) 2089-2098
56. Stiris T., Odden J.P., Hansen T.W., et al. The effect of arterial PCO2-variations on ocular and cerebral blood flow in the newborn piglet. Pediatr Res 25 (1989) 205-208
57. Cunningham S., Symon A.G., and Elton R.A. Intra-arterial blood pressure reference ranges, death and morbidity in very low birthweight infants during the first seven days of life. Early Hum Dev 56 (1999) 151-165
58. Schmidt B., Davis P., and Moddemann D. Long-term effects of indomethacin prophylaxis in extremely low-birth-weight infants. N Engl J Med 344 (2001) 1966-1972
59. Knight D.B. The treatment of patent ductus arteriosus in preterm infants. A review and overview of randomized trials. Semin Neonatol 6 (2001) 63-73
60. Termote J., Schalij-Delfos N.E., Brouwers H.A., et al. New developments in neonatology: less severe retinopathy of prematurity?. J Pediatr Ophthalmol Strabismus 37 (2000) 142-148
61. Penn J.S., Rajaratnam V.S., and Collier R.J. The effect of an angiostatic steroid on neovascularization in a rat model of retinopathy of prematurity. Invest Ophthalmol Vis Sci 42 (2001) 283-290
62. Termote J.U., Schalij-Delfos N.E., Wittebol-Post D., et al. Surfactant replacement therapy: a new risk factor in developing retinopathy of prematurity?. Eur J Pediatr 153 (1994) 113-116
63. Glass P., Avery G.B., Subramanian K.N., et al. Effect of bright light in the hospital nursery on the incidence of retinopathy of prematurity. N Engl J Med 313 7 (1985) 401-404
64. Hommura S., Usuki Y., Takei K., et al. Ophthalmologic care of very low birth weight infants. Report 4. clinical studies of the influence of light on the incidence of retinopathy of prematurity. Nippon Ganka Gakkai Zasshi 92 3 (1988) 456-461
65. Ackerman B., Sherwonit E., and Williams J. Reduced incidental light exposure effect on the development of retinopathy of prematurity in low birth weight infants. Pediatrics 83 6 (1989) 958-962
66. Reynolds J.D., Hardy R.J., Kennedy K.A., et al. Lack of efficacy of light reduction in preventing retinopathy of prematurity. Light Reduction in Retinopathy of Prematurity (LIGHT-ROP) Cooperative Group. N Engl J Med 338 22 (1998) 1572-1576
67. Phelps D.L., and Watts J.L. Early light reduction for preventing retinopathy of prematurity in very low birth weight infants. Cochrane Database Syst Rev 1 (2001) CD000122
68. Console V., Gagliardi L., and De Giorgi A. Retinopathy of prematurity and antenatal corticosteroids. The Italian ROP Study Group. Acta Biomed Ateneo Parmense 68 (1997) 75-79
69. Haroon P.M., and Dhanireddy R. Association of postnatal dexamethasone use and fungal sepsis in the development of severe retinopathy of prematurity and progression to laser therapy in extremely low-birth-weight infants. J Perinatol 21 (2001) 242-247
70. Halliday H.L., and Ehrenkranz R.A. Delayed (>3 weeks) postnatal corticosteroids for chronic lung disease in preterm infants. [Cochrane Review]. Cochrane Database Syst Rev 2 (2001) CD001145
71. Akkoyun I., Oto S., Yilmaz G., et al. Risk factors in the development of mild and severe retinopathy of prematurity. J AAPOS 10 5 (2006) 449-453
72. Dutta S., Narang S., Narang A., et al. Risk factors of threshold retinopathy of prematurity. Indian Pediatr 41 7 (2004) 665-671
73. Cooke R.W., Clark D., Hickey-Dwyer M., et al. The apparent role of blood transfusions in the development of retinopathy of prematurity. Eur J Pediatr 152 (1993) 833-836
74. Dani C., Reali M.F., and Bertini G. The role of blood transfusions and iron intake on retinopathy of prematurity. Early Hum Dev 62 (2001) 57-63
75. Liu P.M., Fang P.C., Huang C.B., et al. Risk factors of retinopathy of prematurity in premature infants weighing less than 1600 g. Am J Perinatol 22 2 (2005) 115-120
76. Shah V.A., Yeo C.L., Ling Y.L., et al. Incidence, risk factors of retinopathy of prematurity among very low birth weight infants in Singapore. Ann Acad Med Singap 34 2 (2005) 169-178
77. Csak K., Szabo V., Szabo A., et al. Pathogenesis and genetic basis for retinopathy of prematurity. Front Biosci 1 11 (2006) 908-920
78. Chiang M.F., Arons R.R., Flynn J.T., et al. Incidence of retinopathy of prematurity from 1996 to 2000: analysis of a comprehensive New York state patient database. Ophthalmology 111 7 (2004) 1317-1325
79. Cooke R.W., Drury J.A., Mountford R., et al. Genetic polymorphisms and retinopathy of prematurity. Invest Ophthalmol Vis Sci 45 6 (2004) 1712-1715
80. O'Keefe M., and Kirwan C. Screening for retinopathy of prematurity. Early Hum Dev 84 (2008) 89-94
81. Subhani M., Combs A., Weber P., et al. Screening guidelines for retinopathy of prematurity: the need for revision in extremely low birth weight infants. Pediatrics 107 4 (2001) 656-659
82. Royal College of Paediatrics & Child Health & Royal College of Ophthalmologists. UK retinopathy of Prematurity Guideline. 2007. Available at: (2007). http://www.rcophth.ac.uk/docs/publications/ROP_Guideline_-_Masterv11-ARF -2.pdf Accessed November 28, 2008
83. Mathew M.R., Fern A.I., and Hill R. Retinopathy of prematurity: are we screening too many babies?. Eye 16 5 (2002) 538-542
84. Ho S.F., Mathew M.R., Wykes W., et al. Retinopathy of prematurity: an optimum screening strategy. J AAPOS 9 6 (2005) 584-588
85. Hutchinson A.K., O'Neil J.W., Morgan E.N., et al. Retinopathy of prematurity in infants with birth weights greater than 1250 grams. J AAPOS 7 3 (2003) 190-194
86. VanderVeen D.K., Mansfield T.A., and Eichenwald E.C. Lower oxygen saturation alarm limits decrease the severity of retinopathy of prematurity. J AAPOS 10 5 (2006) 445-448
87. Coe K., Butler M., Reavis N., et al. Special Premie Oxygen Targeting (SPOT): a program to decrease the incidence of blindness in infants with retinopathy of prematurity. J Nurs Care Qual 21 3 (2006) 230-235
88. Milner R.A., et al. Vitamin E supplement in under 1,500 gram neonates. Retinopathy of Prematurity Conference (1981), Ross Laboratories, Columbus (OH) p. 703-16
89. Finer N.N., Schindler R.F., Grant G., et al. Effect of intramuscular vitamin E on frequency and severity of retrolental fibroplasia: a controlled trial. Lancet 1 8281 (1982) 1087-1091
90. Johnson L., Quinn G.E., Abbasi S., et al. Effect of sustained pharmacologic vitamin E levels on incidence and severity of retinopathy of prematurity: a controlled clinical trial. J Pediatr 114 5 (1989) 827-838
91. Raju T.N., Langenberg P., Bhutani V., et al. Vitamin E prophylaxis to reduce retinopathy of prematurity: a reappraisal of published trials. J Pediatr 131 6 (1997) 844-850
92. Rosenbaum A.L., Phelps D.L., Isenberg S.J., et al. Retinal hemorrhage in retinopathy of prematurity associated with tocopherol treatment. Ophthalmology 92 8 (1985) 1012-1014
93. Phelps D.L., Rosenbaum A.L., Isenberg S.J., et al. Tocopherol efficacy and safety for preventing retinopathy of prematurity: a randomized, controlled, double-masked trial. Pediatrics 79 4 (1987) 489-500
94. Ehrenkranz R.A. Vitamin E and retinopathy of prematurity: still controversial. J Pediatr 114 5 (1989) 801-803
95. Brion L.P., Bell E.F., and Raghuveer T.S. Vitamin E supplementation for prevention of morbidity and mortality in preterm infants. Cochrane Database Syst Rev 4 (2003) CD003665
96. Lakatos L., Hatvani I., Oroszlan G., et al. Controlled trial of D-penicillamine to prevent retinopathy of prematurity. Acta Paediatr Hung 27 (1986) 47-56
97. Lakatos L., Lakatos Z., Hatvani I., et al. Controlled trial of use of D-Penicillamine to prevent retinopathy of prematurity in very low-birth-weight infants. In: Stern L., Oh W., and Friis-Hansen B. (Eds). Physiologic foundations of perinatal care (1987), Elsevier, St. Louis 9-23
98. Phelps D.L., Lakatos L., and Watts J.L. D-Penicillamine for preventing retinopathy of prematurity in preterm infants. Cochrane Database Syst Rev 1 (2001) CD001073
99. Christensen R.D., Alder S.C., Richards S.C., et al. D-Penicillamine administration and the incidence of retinopathy of prematurity. J Perinatol 27 2 (2007) 103-111
100. Hallman M., Jarvanpaa A.L., and Pohjavuori M. Respiratory distress syndrome and inositol supplementation in preterm infants. Arch Dis Child 61 (1986) 1076-1083
101. Hallman M., Bry K., Hoppu K., et al. Inositol supplementation in premature infants with respiratory distress syndrome. N Engl J Med 326 19 (1992) 1233-1239
102. Howlett A., and Ohlsson A. Inositol for respiratory distress syndrome in preterm infants. Cochrane Database Syst Rev 4 (2003) CD000366
103. Saito Y., Geisen P., Uppal A., et al. Inhibition of NAD(P)H oxidase reduces apoptosis and avascular retina in an animal model of retinopathy of prematurity. Mol Vis 13 (2008) 840-853
104. Geisen P., Peterson L.J., Martiniuk D., et al. Neutralizing antibody to VEGF reduces intravitreous neovascularization and may not interfere with ongoing intraretinal vascularization in a rat model of retinopathy of prematurity. Mol Vis 14 (2008) 345-357
105. Steinmetz R.L., and Brooks Jr. H.L. Diode laser photocoagulation to the ridge and avascular retina in threshold retinopathy of prematurity. Retina 22 1 (2002) 48-52
106. Hubbard III G.B. Surgical management of retinopathy of prematurity. Curr Opin Ophthalmol 19 5 (2008) 384-390
107. Early Treatment For Retinopathy Of Prematurity Cooperative Group. Revised indications for the treatment of retinopathy of prematurity: results of the early treatment for retinopathy of prematurity randomized trial. Arch Ophthalmol 121 12 (2003) 1684-1694
108. Wallace D.K., Quinn G.E., Freedman S.F., et al. Agreement among pediatric ophthalmologists in diagnosing plus and preplus disease in retinopathy of prematurity. J AAPOS 12 4 (2008) 352-356
109. Johnson K.S., Mills M.D., Karp K.A., et al. Semiautomated analysis of retinal vessel diameter in retinopathy of prematurity patients with and without plus disease. Am J Ophthalmol 143 (2007) 723-725
110. Wallace D.K., Freedman S.F., Zhao Z., et al. Accuracy of ROPtool vs individual examiners in assessing retinal vascular tortuosity. Arch Ophthalmol 125 (2007) 1523-1530
111. Swanson C., Cocker K.D., Parker K.H., et al. Semiautomated computer analysis of vessel growth in preterm infants without and with ROP. Br J Ophthalmol 87 (2003) 1474-1477
112. Coats D., and Saunders R. The dilemma of exercising clinical judgment in the treatment of retinopathy of prematurity. Arch Ophthalmol 123 (2005) 408-409
113. Fielder A.R. Cryotherapy of retinopathy of prematurity. In: Davidson S.I., and Jay B. (Eds). Recent advances in ophthalmology vol 8 (1992), Churchill Livingstone, Edinburgh (UK) 129-148
114. Hutcheson K.A. Retinopathy of prematurity. Curr Opin Ophthalmol 14 5 (2003) 286-290
115. Phelps D.L. Retinopathy of prematurity. Curr Probl Pediatr 22 8 (1992) 349-371
116. Cryotherapy for Retinopathy of Prematurity Cooperative Group. Multicenter trial of cryotherapy for retinopathy of prematurity. Three-month outcome. Arch Ophthalmol 108 2 (1990) 195-204
117. Cryotherapy for Retinopathy of Prematurity Cooperative Group. Multicenter trial of cryotherapy for retinopathy of prematurity: one-year outcome-structure and function. Arch Ophthalmol 108 10 (1990) 1408-1416
118. Cryotherapy for Retinopathy of Prematurity Cooperative Group. Multicenter Trial of Cryotherapy for Retinopathy of Prematurity: ophthalmological outcomes at 10 years. Arch Ophthalmol 119 8 (2001) 1110-1118
119. Higgins R. Retinopathy of prematurity. E-Medicine (2006). Available at: www.emedicine.com/ped/topic1998.htm Accessed March 25, 2007
120. Ng E.Y., Connolly B.P., McNamara J.A., et al. A comparison of laser photocoagulation with cryotherapy for threshold retinopathy of prematurity at 10 years: part 1. Visual function and structural outcome. Ophthalmology 109 5 (2002) 928-934
121. Connolly B.P., Ng E.Y., McNamara J.A., et al. A comparison of laser photocoagulation with cryotherapy for threshold retinopathy of prematurity at 10 years: part 2. Refractive outcome. Ophthalmology 109 5 (2002) 936-941
122. Paysse E.A., Lindsey J.L., Coats D.K., et al. Therapeutic outcomes of cryotherapy versus transpupillary diode laser photocoagulation for threshold retinopathy of prematurity. J AAPOS 3 4 (1999) 234-240
123. Hunter D.G., and Repka M.X. Diode laser photocoagulation for threshold retinopathy of prematurity. A randomized study. Ophthalmology 100 2 (1993) 238-244
124. Laser ROP Study Group. Laser therapy for retinopathy of prematurity. Arch Ophthalmol 112 (1994) 154-156
125. Ling C.S., Fleck B.W., Wright E., et al. Diode laser treatment for retinopathy of prematurity: structural and functional outcome. Br J Ophthalmol 79 (1995) 637-641
126. White J.E., and Repka M.X. Randomized comparison of diode laser photocoagulation versus cryotherapy for threshold retinopathy of prematurity: 3-year outcome. J Pediatr Ophthalmol Strabismus 34 (1997) 83-87
127. Shalev B., Farr A.K., and Repka M.X. Randomized comparison of diode laser photocoagulation versus cryotherapy for threshold retinopathy of prematurity: seven-year outcome. Am J Ophthalmol 132 (2001) 76-80
128. Andersen C.C., and Phelps D.L. Peripheral retinal ablation for threshold retinopathy of prematurity in preterm infants. Cochrane Database Syst Rev 2 (2000) CD001693
129. Phelps DL, Retinopathy of prematurity: a practical clinical approach. NeoReviews 2001;2(7):e174-9
130. McNamara J.A. Laser treatment for retinopathy of prematurity. Curr Opin Ophthalmol 4 (1993) 76-80
131. Topilow H.W., and Ackerman A.L. Cryotherapy for stage 3+ retinopathy of prematurity: visual and anatomic results. Ophthalmic Surg 20 12 (1989) 864-871
132. Noorily S.W., Small K., de Juan Jr. E., et al. Scleral buckling surgery for stage 4B retinopathy of prematurity. Ophthalmology 99 (1992) 263-268
133. Trese M.T. Scleral buckling for retinopathy of prematurity. Ophthalmology 101 (1994) 23-26
134. Hinz B.J., deJuan Jr. E., and Repka M.X. Scleral buckling surgery for active stage 4A retinopathy of prematurity. Ophthalmology 105 (1998) 1827-1830
135. Hubbard III G.B., Cherwick D.H., and Burian G. Lens-sparing vitrectomy for stage 4 retinopathy of prematurity. Ophthalmology 111 (2004) 2274-2277
136. Lakhanpal R.R., Sun R.L., Albini T.A., et al. Anatomic success rate after 3-port lens-sparing vitrectomy in stage 4A or 4B retinopathy of prematurity. Ophthalmology 112 (2005) 1569-1573
137. Prenner J.L., Capone Jr. A., and Trese M.T. Visual outcomes after lens sparing vitrectomy for stage 4A retinopathy of prematurity. Ophthalmology 111 (2004) 2271-2273
138. Repka M.X., Tung B., Good W.V., et al. Outcome of eyes developing retinal detachment during the Early Treatment for Retinopathy of Prematurity Study (ETROP). Arch Ophthalmol 124 1 (2006) 24-30
139. Sears J.E., and Sonnie C. Anatomic success of lens-sparing vitrectomy with and without scleral buckle for stage 4 retinopathy of prematurity. Am J Ophthalmol 143 5 (2007) 810-813
140. Ferrone P.J., Harrison C., and Trese M.T. Lens clarity after lens-sparing vitrectomy in a pediatric population. Ophthalmology 104 (1997) 273-278
141. Lakhanpal R.R., Davis G.H., Sun R.L., et al. Lens clarity after threeport lens-sparing vitrectomy in stage 4A and 4B retinal detachments secondary to retinopathy of prematurity. Arch Ophthalmol 124 1 (2006) 20-23
142. Hartnett M.E. Features associated with surgical outcome in patients with stages 4 and 5 retinopathy of prematurity. Retina 23 3 (2003) 322-329
143. Spaide R.F., and Fisher Y.L. Intravitreal bevacizumab (Avastin) treatment of proliferative diabetic retinopathy complicated by vitreous hemorrhage. Retina 26 (2006) 275-278
144. Avery R.L., Pieramici D.J., Rabena M.D., et al. Intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration. Ophthalmology 113 (2006) 363e5-372e5
145. Chung E.J., Kim J.H., Ahn H.S., et al. Combination of laser photocoagulation and intravitreal bevacizumab (Avastin) for aggressive zone I retinopathy of prematurity. Graefes Arch Clin Exp Ophthalmol 245 (2007) 1727-1730
146. Shah P.K., Narendran V., Tawansy K.A., et al. Intravitreal bevacizumab (Avastin) for post laser anterior segment ischemia in aggressive posterior retinopathy of prematurity. Indian J Ophthalmol 55 (2007) 75-76
147. Travassos A., Teixeira S., Ferreira P., et al. Intravitreal bevacizumab in aggressive posterior retinopathy of prematurity. Ophthalmic Surg Lasers Imaging 38 (2007) 233-237
148. Cryotherapy for Retinopathy of Prematurity Cooperative Group. Multicenter trial of cryotherapy for retinopathy of prematurity. Snellen visual acuity and structural outcome at 5 1/2 years after randomisation. Arch Ophthalmol 114 (1996) 417-442
149. Ruth A., Hutchinson A.K., and Hubbard III G.B. Late vitreous hemorrhage in patients with regressed retinopathy of prematurity. J AAPOS 12 (2008) 181-185
150. Tasman W., and Brown G.C. Progressive visual loss in adults with retinopathy of prematurity (ROP). Trans Am Ophthalmol Soc 86 (1988) 367-379
151. Cats B.P., and Tan K.E. Prematures with and without regressed retinopathy of prematurity: comparison of long-term (6-10 years) ophthalmological morbidity. J Pediatr Ophthalmol Strabismus 26 6 (1989) 271-275
152. Cryotherapy for Retinopathy of Prematurity Cooperative Group. Multicenter trial of cryotherapy for retinopathy of prematurity: natural history ROP: ocular outcome at 5(1/2) years in premature infants with birth weights less than 1251 g. Arch Ophthalmol 120 5 (2002) 595-599